Expression of COX-2 in 50 glioma patients, as determined by immunohistochemistry
A. Score of positive tumor cellsa . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | |||||
GBM | 0 | 0 | 1 | 8 | 16 | |||||
AA | 0 | 0 | 4 | 5 | 1 | |||||
LOW | 3 | 3 | 8 | 1 | 0 |
A. Score of positive tumor cellsa . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | |||||
GBM | 0 | 0 | 1 | 8 | 16 | |||||
AA | 0 | 0 | 4 | 5 | 1 | |||||
LOW | 3 | 3 | 8 | 1 | 0 |
B. Staining intensityb . | . | . | . | |||
---|---|---|---|---|---|---|
. | 0 . | 1+ . | 2+ . | |||
GBM | 0 | 9 | 16 | |||
AA | 0 | 1 | 9 | |||
LOW | 0 | 15 | 0 |
B. Staining intensityb . | . | . | . | |||
---|---|---|---|---|---|---|
. | 0 . | 1+ . | 2+ . | |||
GBM | 0 | 9 | 16 | |||
AA | 0 | 1 | 9 | |||
LOW | 0 | 15 | 0 |
C. Immunoreactive scorec . | . | . | . | . | . | . | . | . | . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | |||||||||
GBM | 0 | 0 | 1 | 6 | 2 | 1 | 1 | 7 | 7 | |||||||||
AA | 0 | 0 | 1 | 1 | 2 | 0 | 5 | 0 | 1 | |||||||||
LOW | 3 | 3 | 8 | 1 | 0 | 0 | 0 | 0 | 0 |
C. Immunoreactive scorec . | . | . | . | . | . | . | . | . | . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 4 . | 5 . | 6 . | 7 . | 8 . | |||||||||
GBM | 0 | 0 | 1 | 6 | 2 | 1 | 1 | 7 | 7 | |||||||||
AA | 0 | 0 | 1 | 1 | 2 | 0 | 5 | 0 | 1 | |||||||||
LOW | 3 | 3 | 8 | 1 | 0 | 0 | 0 | 0 | 0 |